German company Bayer to invest $2.2b in new US production site
German pharmaceutical and agrochemical company Bayer on Friday said it plans to invest $2.2 billion in a new production site in the United States. The post German company Bayer to invest $2.2b in new US production site appeared first on Ghana Business News .
Pharmaceutical and agrochemical giant Bayer announced on Friday an investment of $2.2 billion for a new production site in the United States. The new plant, located in New Albany, Ohio, will be unique in its capability to manufacture both pharmaceutical active ingredients and finished medicines under one roof. This move is anticipated to generate approximately 600 well-skilled jobs in the region.
"We have always viewed the United States as a vital manufacturing hub and innovation center," stated Bayer's CEO, Bill Anderson. "The new facility will serve as a home for our manufacturing expertise and a talented workforce, reinforcing our capacity to provide innovative, top-tier medicines to patients both within the United States and globally."
Over the last five years, Bayer has poured over $7 billion into pharmaceutical research and development, as well as production facilities in the US.
Written by urgent.news from Ghana Business News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
